Dual action of the PN159/KLAL/MAP peptide

Increase of drug penetration across caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability

Alexandra Bocsik, Ilona Gróf, L. Kiss, F. Ötvös, Ottó Zsíros, Lejla Daruka, L. Fülöp, Monika Vastag, A. Kittel, Norbert Imre, T. Martinek, C. Pál, P. Szabó-Révész, Mária A. Deli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The absorption of drugs is limited by the epithelial barriers of the gastrointestinal tract. One of the strategies to improve drug delivery is the modulation of barrier function by the targeted opening of epithelial tight junctions. In our previous study the 18-mer amphiphilic PN159 peptide was found to be an effective tight junction modulator on intestinal epithelial and blood–brain barrier models. PN159, also known as KLAL or MAP, was described to interact with biological membranes as a cell-penetrating peptide. In the present work we demonstrated that the PN159 peptide as a penetration enhancer has a dual action on intestinal epithelial cells. The peptide safely and reversibly enhanced the permeability of Caco-2 monolayers by opening the intercellular junctions. The penetration of dextran molecules with different size and four efflux pump substrate drugs was increased several folds. We identified claudin-4 and -7 junctional proteins by docking studies as potential binding partners and targets of PN159 in the opening of the paracellular pathway. In addition to the tight junction modulator action, the peptide showed cell membrane permeabilizing and antimicrobial effects. This dual action is not general for cell-penetrating peptides (CPPs), since the other three CPPs tested did not show barrier opening effects.

Original languageEnglish
Article number73
JournalPharmaceutics
Volume11
Issue number2
DOIs
Publication statusPublished - Feb 6 2019

Fingerprint

Cell-Penetrating Peptides
Tight Junctions
Permeability
Cell Membrane
Claudin-4
Pharmaceutical Preparations
Peptides
Intercellular Junctions
Dextrans
Gastrointestinal Tract
Epithelial Cells
Membranes
KLAL peptide
Proteins

Keywords

  • Absorption enhancer
  • Antimicrobial peptide
  • Caco-2
  • Cell-penetrating peptide (CPP)
  • Claudin
  • Drug delivery
  • Intestinal epithelial cells
  • KLAL
  • PN159
  • Tight junction modulator

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Dual action of the PN159/KLAL/MAP peptide : Increase of drug penetration across caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability. / Bocsik, Alexandra; Gróf, Ilona; Kiss, L.; Ötvös, F.; Zsíros, Ottó; Daruka, Lejla; Fülöp, L.; Vastag, Monika; Kittel, A.; Imre, Norbert; Martinek, T.; Pál, C.; Szabó-Révész, P.; Deli, Mária A.

In: Pharmaceutics, Vol. 11, No. 2, 73, 06.02.2019.

Research output: Contribution to journalArticle

@article{1821cfa09ed44e5b889d37afc49e716f,
title = "Dual action of the PN159/KLAL/MAP peptide: Increase of drug penetration across caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability",
abstract = "The absorption of drugs is limited by the epithelial barriers of the gastrointestinal tract. One of the strategies to improve drug delivery is the modulation of barrier function by the targeted opening of epithelial tight junctions. In our previous study the 18-mer amphiphilic PN159 peptide was found to be an effective tight junction modulator on intestinal epithelial and blood–brain barrier models. PN159, also known as KLAL or MAP, was described to interact with biological membranes as a cell-penetrating peptide. In the present work we demonstrated that the PN159 peptide as a penetration enhancer has a dual action on intestinal epithelial cells. The peptide safely and reversibly enhanced the permeability of Caco-2 monolayers by opening the intercellular junctions. The penetration of dextran molecules with different size and four efflux pump substrate drugs was increased several folds. We identified claudin-4 and -7 junctional proteins by docking studies as potential binding partners and targets of PN159 in the opening of the paracellular pathway. In addition to the tight junction modulator action, the peptide showed cell membrane permeabilizing and antimicrobial effects. This dual action is not general for cell-penetrating peptides (CPPs), since the other three CPPs tested did not show barrier opening effects.",
keywords = "Absorption enhancer, Antimicrobial peptide, Caco-2, Cell-penetrating peptide (CPP), Claudin, Drug delivery, Intestinal epithelial cells, KLAL, PN159, Tight junction modulator",
author = "Alexandra Bocsik and Ilona Gr{\'o}f and L. Kiss and F. {\"O}tv{\"o}s and Ott{\'o} Zs{\'i}ros and Lejla Daruka and L. F{\"u}l{\"o}p and Monika Vastag and A. Kittel and Norbert Imre and T. Martinek and C. P{\'a}l and P. Szab{\'o}-R{\'e}v{\'e}sz and Deli, {M{\'a}ria A.}",
year = "2019",
month = "2",
day = "6",
doi = "10.3390/pharmaceutics11020073",
language = "English",
volume = "11",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Dual action of the PN159/KLAL/MAP peptide

T2 - Increase of drug penetration across caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability

AU - Bocsik, Alexandra

AU - Gróf, Ilona

AU - Kiss, L.

AU - Ötvös, F.

AU - Zsíros, Ottó

AU - Daruka, Lejla

AU - Fülöp, L.

AU - Vastag, Monika

AU - Kittel, A.

AU - Imre, Norbert

AU - Martinek, T.

AU - Pál, C.

AU - Szabó-Révész, P.

AU - Deli, Mária A.

PY - 2019/2/6

Y1 - 2019/2/6

N2 - The absorption of drugs is limited by the epithelial barriers of the gastrointestinal tract. One of the strategies to improve drug delivery is the modulation of barrier function by the targeted opening of epithelial tight junctions. In our previous study the 18-mer amphiphilic PN159 peptide was found to be an effective tight junction modulator on intestinal epithelial and blood–brain barrier models. PN159, also known as KLAL or MAP, was described to interact with biological membranes as a cell-penetrating peptide. In the present work we demonstrated that the PN159 peptide as a penetration enhancer has a dual action on intestinal epithelial cells. The peptide safely and reversibly enhanced the permeability of Caco-2 monolayers by opening the intercellular junctions. The penetration of dextran molecules with different size and four efflux pump substrate drugs was increased several folds. We identified claudin-4 and -7 junctional proteins by docking studies as potential binding partners and targets of PN159 in the opening of the paracellular pathway. In addition to the tight junction modulator action, the peptide showed cell membrane permeabilizing and antimicrobial effects. This dual action is not general for cell-penetrating peptides (CPPs), since the other three CPPs tested did not show barrier opening effects.

AB - The absorption of drugs is limited by the epithelial barriers of the gastrointestinal tract. One of the strategies to improve drug delivery is the modulation of barrier function by the targeted opening of epithelial tight junctions. In our previous study the 18-mer amphiphilic PN159 peptide was found to be an effective tight junction modulator on intestinal epithelial and blood–brain barrier models. PN159, also known as KLAL or MAP, was described to interact with biological membranes as a cell-penetrating peptide. In the present work we demonstrated that the PN159 peptide as a penetration enhancer has a dual action on intestinal epithelial cells. The peptide safely and reversibly enhanced the permeability of Caco-2 monolayers by opening the intercellular junctions. The penetration of dextran molecules with different size and four efflux pump substrate drugs was increased several folds. We identified claudin-4 and -7 junctional proteins by docking studies as potential binding partners and targets of PN159 in the opening of the paracellular pathway. In addition to the tight junction modulator action, the peptide showed cell membrane permeabilizing and antimicrobial effects. This dual action is not general for cell-penetrating peptides (CPPs), since the other three CPPs tested did not show barrier opening effects.

KW - Absorption enhancer

KW - Antimicrobial peptide

KW - Caco-2

KW - Cell-penetrating peptide (CPP)

KW - Claudin

KW - Drug delivery

KW - Intestinal epithelial cells

KW - KLAL

KW - PN159

KW - Tight junction modulator

UR - http://www.scopus.com/inward/record.url?scp=85063515175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063515175&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics11020073

DO - 10.3390/pharmaceutics11020073

M3 - Article

VL - 11

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 2

M1 - 73

ER -